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Abstract: Splicing events do not always produce a linear transcript. Circular RNAs (circRNAs) are
a class of RNA that are emerging as key new members of the gene regulatory milieu, which are
produced by back-splicing events within genes. In circRNA formation, rather than being spliced
in a linear fashion, exons can be circularised by use of the 3′ acceptor splice site of an upstream
exon, leading to the formation of a circular RNA species. circRNAs have been demonstrated across
species and have the potential to present genetic information in new orientations distinct from their
parent transcript. The importance of these RNA players in gene regulation and normal cellular
homeostasis is now beginning to be recognised. They have several potential modes of action, from
serving as sponges for micro RNAs and RNA binding proteins, to acting as transcriptional regulators.
In accordance with an important role in the normal biology of the cell, perturbations of circRNA
expression are now being reported in association with disease. Furthermore, the inherent stability of
circRNAs conferred by their circular structure and exonuclease resistance, and their expression in
blood and other peripheral tissues in association with endosomes and microvesicles, renders them
excellent candidates as disease biomarkers. In this review, we explore the state of knowledge on this
exciting class of transcripts in regulating gene expression and discuss their emerging role in health
and disease.
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1. Introduction
Circular RNAs (circRNAs) are an emerging class of RNA species that are present in species as
diverse as archaea, flies, and humans [1–4]. circRNAs in higher organisms are reported to be produced
by back-splicing events and can be synthesized from all regions of the genome, deriving mostly from
exons but, less commonly, from antisense, intergenic, intragenic, or intronic regions [5]. circRNAs are
both spatially and temporally regulated and evidence is emerging that they may have importance
in normal development of tissues or organs but also in disease pathogenesis. Most circRNAs have
been reported in the brain [2,6–8]. They can be found in most cell sub-compartments, but the majority
localize predominantly to the cytoplasm [9]. circRNAs are inherently stable by virtue of their closed
covalent structure and exonuclease resistance and are thought to be stable in exosomes [2,5,10–12].
This observation opens up the interesting possibility that circRNAs, like micro RNAs (miRNAs), may
have roles in paracrine signalling or have roles in cell-to-cell cross talk.
2. circRNAs Are Formed from Back-Splicing Events of Linear Genes
In conventional linear splicing, the spliceosome joins exons in a 5′ to 3′ configuration. In contrast,
circRNAs arise when the 3′ ‘tail’ of a downstream exon of a gene is back-spliced to the 5′ ‘head’
of an earlier exon (which may include itself) leading to the circularization of exons in between
(see Figure 1) [10]. These splicing decisions are, as in linear splicing, regulated by trans-acting splicing
factors and cis sequence elements [13]. Several sequence features influencing circRNA formation have
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been described. Firstly, intron length has been reported to play a part; introns flanking back-spliced
sites tend to be comparatively longer than those flanking non-circularised exons [4]. This may
be because larger introns may form more RNA–RNA interactions, facilitating circularization of
embedded exons; the double-stranded RNA-editing enzyme ADAR1, which is capable of melting stem
structures within these RNA–RNA interactions, is associated with suppression of circRNA expression
in Caenorhabditis elegans [14]. Secondly, exon length may also be a factor; exons of single-exon circRNAs
are on average 3-fold longer compared with those of non-circularised exons; longer exons may be
sterically preferentially favoured for 3′–5′ splicing at canonical splice sites [2,15,16]. Thirdly, RNAs
that are hyper-edited are enriched for circRNA sequences [14]. Finally, sequence content may also be
important. Repetitive sequences are known to promote back splicing; back-spliced exons that form
circRNAs are frequently enriched in paired ALU tandem repeats that have been shown to promote
circularization [2]. Miniature introns with as few as 30 to 40-nt inverted repeats are also sufficient to
promote circularization [17].
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Figure 1. The biogenesis of circular RNA (circRNA). The linear primary transcript contains exons 
(blue boxes), introns (black lines), and possibly repetitive elements or sequence motifs (grey boxes). 
Circular exons are generated from back-splicing events between the splice donor site of a downstream 
exon and the splice acceptor site of an upstream exon. This can be mediated by specific sequence 
elements (grey boxes) or by interaction with RNA binding proteins (RBPs). Splicing events are 
indicated by dashed lines with double arrowheads. This may result in the production of a circular 
RNA and a linear RNA which lacks the circularised exons.  
circRNA formation may also be dependent on the specific binding of regulatory proteins. RNA 
binding proteins such as Quaking (QKI) and Muscleblind (MBL/MBNL1) have been described to bind 
to introns flanking back-spliced sites and may drive circularization [18,19]. The MBL gene itself 
encodes a circular form which regulates the expression of its linear transcript and modulation of MBL 
levels strongly affects circMBL expression [18]. circRNA formation has also been shown to depend 
on the rate of transcription of their parent genes. circRNA producing genes are generally longer and 
exhibit faster transcription than genes that do not produce circRNAs, and artificially slowing the rate 
of transcription with mutant RNA polymerases results in lower levels of circRNA biogenesis [20].  
Intronic circRNAs (ciRNAs) can also be generated form lariat introns. ciRNAs are devoid of 
linear fragments spanning the 3′ end of the intron to the branch point, but are produced by a 2′,5′-
phosphodiester bond arising from canonical linear splicing [21]. A 7-nt GU-rich element occurring 
Figure 1. The biogenesis of circular RNA (circRNA). The linear primary transcript contains exons
(blue boxes), introns (black lines), and possibly repetitive elements or sequence motifs (grey boxes).
Circular exons are generated from back-splicing events between the splice donor site of a downstream
exon and the splice acceptor site of an upstream exon. This can be mediated by specific sequence
elements (grey boxes) or by interaction with RNA binding proteins (RBPs). Splicing events are indicated
by dashed lines with double arrowheads. This may result in the production of a circular RNA and a
linear RNA which lacks the circularised exons.
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close to a 5′ splice site and with an 11-nt C-rich motif around the branch point within intronic sequences
has been reported to be important for formation of ciRNAs [21].
3. circRNA Online Resources
Over the past few years, at least eleven circRNA detection software systems have been developed.
These tools can recognize circRNA sequences from RNA-Seq data based on two different strategies.
One approach is the candidate-based approach, also known as the pseudo-reference based approach.
KNIFE, NCLScan, and PTESFinder all abide by this approach where putative circRNA sequences
need to be provided with information for gene annotation. Although KNIFE can directly retrieve
back-spliced junctions prior to gene annotations, the other two software systems generate putative
circRNA sequences post-alignment with the genome or transcriptome [22–24].
circRNA_finder, CIRCexplorer, DCC, MapSplice, Segemehl, find-circ, and UROBORUS detect
circRNA sequences based on the second approach for identification of circRNA sequences which is
the fragmented-base or segmented read approach. In this approach, the software detects back-spliced
sites based on reads mapped to alignment of multiple split reads against the genome. While find-circ
and UROBORUS detect back-spliced sequences using the first and last 20 bp after mapping the
sequences against the genomes, the rest of the detection tools generate splice alignment algorithms to
identify back-spliced junctions [22–24]. CIRI is a distinct detection tool in that it extracts information
from local alignment with Burrows-Wheeler Aligner-MEM (BWA-MEM) and detects paired chiastic
clipping signals from mapped reads (arXiv:1303.3997). Comparisons of the different circRNA detection
algorithms have now been made, which add information on the relative strengths and caveats of these
different approaches [25]. Searchable repositories for circRNA sequences such as circBase are also now
emerging [26], which should prove useful to researchers interested in these RNA species in the future.
4. Molecular Mechanisms of Gene Regulation by circRNAs
circRNAs have been proposed to act through several mechanisms, including miRNA sponges,
modifiers of transcription or translation, and as splicing modifiers (Figure 2).
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Figure 2. Proposed roles of circR in the regulation of transcription and translation. circRNAs
may regulate genes at several levels. (A) Firstly, nuclear circRNAs can interact with promoter
regions of target genes and interact with RNA polymerase II (Pol2) to repress or enhance transcription;
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(B) Secondly, circRNAs can sequester RBPs that regulate mRNA processing and, thus, alter the splicing
patterns of the genes in question, or moderate mRNA stability. RBP binding sites are given by dark
blue boxes; (C) Thirdly, the biogenesis of circular RNAs may results in the production of a linear
RNA lacking the circularised exons. The formation of circRNAs can thus reduce the amount of linear
transcript produced; (D) circRNAs can act as micro RNA (miRNA) sponges, sequestering them away
from their binding sites in target genes, which are given by dark blue boxes; (E) Circular RNAs can also
be translated. The initiation codon is given by a black oval, and the translating ribosome and nascent
polypeptide are indicated.
4.1. circRNAs as miRNA Sponges
circRNA can bind specific miRNAs or groups of miRNAs, sequestering them and suppressing
their function [27], in a phenomenon termed the competitive endogenous RNA hypothesis [28].
circRNA CDR1as has been documented to contain up to 74 binding sites for the miRNA miR-7, and also
binds Argonaute (AGO) proteins of the RNA-induced silencing complex (RISC) that regulate miRNA
action [29]. There is also some suggestion that the relationships between circRNAs and miRNAs
may be partly autoregulatory; CDR1as also binds miR-671, which induces AGO-mediated cleavage
of CDR1as itself, which could act to release miR-7 [30]. However, circRNAs containing multiple
binding sites for single miRNAs may be the exception rather than the rule since most circRNAs
identified to date do not contain enrichment of binding sites for specific miRNAs [31]. Emerging
evidence suggests that circRNAs may act by sequestration of modules of coordinately regulated
miRNAs; the circRNA circHIPK3 contains binding sites for nine miRNAs with growth-suppressive
properties [32]. The presence of multiple binding sites may not be a prerequisite for efficient miRNA
regulation, however, since circHIPK3 contains only two binding sites for miR-124, yet retains the
ability to regulate this miRNA [32]. Most of the research investigating the role of the circRNA–miRNA
interaction has been performed through correlation of the levels of miRNA and circRNA expression
in vitro. Evidence for circRNAs acting as miRNA sponges can also be seen in data arising from the
CDR1as knockout mouse. Levels of both miR-7 and miR-671 were seen to be lower in knockout animals,
and these changes were also correlated with defects in synaptic transmission [33]. It is likely that a
circRNA with multiple binding sites will affect the expression of a larger number of miRNA targets.
However, experimental validation of the minimal number of miRNA binding sites for a candidate
circRNA to be functional is still required for many circRNAs. An arena to explore is whether a single
miRNA binding site would be sufficient for efficient circRNA:miRNA sponging interactions. It would
be also interesting to know what levels of circRNA expression is required for the optimal miRNA
sequestration ability of these entities. The interaction between circRNAs and miRNAs may also go
beyond their role in miRNA sequestration; they may also be important for the storage, sorting, and
localization of miRNAs, adding an additional level of regulation to miRNA-controlled regulation of
target genes [27,34].
4.2. circRNAs as Transcriptional and Translational Regulators
A specific category of circRNAs, nuclear exon-intron circRNAs (EIciRNAs) can also interact
with the transcription machinery. These variant circRNAs, which retain some intronic sequence
from their linear gene, can interact with the U1 component of the spliceosomal machinery, recruiting
RNA polymerase II to the promoter region of genes and enhancing expression of its target genes [35].
circRNAs can also modulate the expression of the cognate transcript if the circularisation event includes
the translation initiation codon of its native gene. This may cause their cognate linear mRNAs arising
from the same gene to escape translation, thus regulating protein expression as in the case of circHIPK3,
circDMD, and circFMN [2,36–38]. Recently, circPABPN1 has been reported to supress binding of
PABPN1 mRNA to HuR. PABPN1 translation is positively associated with HuR and the interaction of
circPABPN1 interaction with HuR reduces the translational efficiency of PABPN1 transcripts. Thus,
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circRNAs like circPABPN1 can act as competitors with their cognate mRNA for RBPs and can also
modulate the rate of translation of target mRNAs [39].
4.3. circRNAs as Competitors of Linear Splicing
All isoforms produced from a given gene arise from a common pre-mRNA. It follows, therefore,
that the production of a circRNA may have consequences for the abundance of the remaining
transcripts encoded by that gene. An example of this lies in the Muscleblind (MBL) gene. MBL contains
sequences that form a circRNA transcript that contains binding sites for MBL itself. Production of the
circMBL therefore forms an autoregulatory loop that regulates the production of the linear transcript
in favour of the circular form [18]. In Arabidopsis, a circRNA derived from the SEPALLATA3 gene has
been shown to interact with its cognate DNA, forming a R-loop and causing a pause in transcription
and also affecting recruitment of splicing factors to the nascent transcript and affecting alternative
splicing through exon-skipping [40].
4.4. circRNAs as Sponges (RBPs)
In addition to their role as miRNA sponges, circRNAs can also act as sponges for other entities
such as RBPs that can regulate gene expression. RBPs, like miRNAs, bind specific sequences within
their target genes and control all stages within the lifecycle of an mRNA from splicing and nuclear
export to stability and subcellular localisation [36]. circRNAs interacting with RNA binding protein
components of the gene regulatory machinery such as HuR have been reported [39].
5. Translation of circRNAs
Recent in vitro studies have shown that circRNAs have potential to encode proteins. Ribosome
footprinting studies in vivo in Drosophila clearly demonstrate that circRNAs are associated with
translating polysomes [41]. Accordingly, some circRNA-derived proteins have been identified.
For example, circ-FBXW7 has been shown to encode a novel protein in human U251 and U373
cell lines [42]. The inclusion of N6-meythyl adenosine residues is sufficient to promote the initiation
of translation of circRNAs in the human cell lines in the presence of initiation factor eIF4G2 and
YTHDF3 [43]. Methyltransferase METTL3/14 also accelerates the initiation of translation of this
circRNA [43]. Computational analysis of high-throughput sequencing data revealed that the human
transcriptome commonly harbours many circRNAs with coding potential. Smaller circRNAs with
relatively fewer exons but longer open reading frames (ORFs) have been reported to be associated
with polysomes [43]. For example, circ-ZNF609 has been demonstrated to encode a protein in a
splicing-dependent but cap-independent manner in human and murine myoblasts. In vitro analysis of
circ-ZNF609 (which contains two start codons) revealed that the circRNA could generate two protein
isoforms corresponding to the two ORFs [6].
6. The Roles of circRNAs in Normal Homeostasis
circRNAs are emerging as important regulators of many cellular processes, such as embryonic
development, control of cell cycle, cellular senescence, cell signalling, and response to cellular stress.
6.1. circRNAs in Embryonic Development
Approximately 10.4% of human circRNAs and 34.3% of mouse circRNAs are expressed in a
tissue specific or age-specific manner, which indicates their potential role in tissue development or
differentiation [44]. The difference in abundance of circRNAs between human and mouse is interesting
and may represent a real species difference, but may also be a reflection of limited power due to
smaller sample numbers of ex vivo human studies because of the inherent difficulties in procuring
non-accessible tissues. The albumin (ALB) gene generates up to 160 circRNA species, of which
95 are specific to adult liver and only 33 are expressed in developing foetal liver [44]. circRNAs
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are enriched in the brain and appear to have particular importance in brain development of this
organism. CiRS-7 has been shown to be highly expressed in the cerebellum at embryonic stage E115,
but reduced in the cerebral cortex at E60 in embryonic pigs [7]. Embryonic, early postnatal, postnatal,
and late postnatal hippocampus from brain samples from embryonic mice also had increased levels of
circDlgap1, circMyst4, circKlhl2, and circAagab. Expression was localized to the punctate in the dendrites,
and abundance fluctuated depending on the stage of synaptogenesis, suggesting that these circRNAs
might be involved in synaptic function during developmental stages [45]. CDR1as may have important
roles in development, since transgenic expression of this circRNA in zebrafish embryos produces fry
with smaller midbrain size, which resembles the phenotype of miR-7 knockdown [29]. The SRY gene
is located in the sex-determining region of the Y chromosome. Mutations in the coding regions of
SRY can lead to change in sex [46,47]. Mouse circSRY has multiple miR-138 binding sites suggesting a
potential role for this circRNA in the regulation of sex determination in mice [29,30].
6.2. circRNAs in Metabolism
High CDR1as expression has been shown to have effects on beta-cell function through its
regulation of miR-7 in pancreatic beta cells. miR-7 targets include the protein kinase C beta (PKCB)
gene involved in cellular signalling, the profilin 2 (PFN2), and phosphatase and actin regulator 1
(PHACTR1) genes involved in cytoskeletal organisation and the gene encoding the transcription factor
paired box 6 (PAX6). This may have profound implications for beta cell function; up-regulation of
murine Pax6 expression through the sponging action of CDR1as on miR-7 has been shown to lead to
increased insulin secretion in mouse islets [48]. miR-7 is abundant in adult islets and may prevent
β cell proliferation by inactivating the mTOR pathway [49].
6.3. circRNAs in Regulation of Cell Cycle
circRNAs have been found to be involved in the progression of the cell cycle. circFOXO3 has been
shown to engage with p21 and cyclin-dependent kinase 2 (CDK2) proteins to form a ternary structure.
The complex formed prevents CDK2 from interacting with cyclin E and p27, which eventually blocks
transition from G1 to S phase and cell cycle progression. Similarly, p21, like CDK2, is unavailable for
interaction with cyclin A, which leads to cell cycle arrest at G1 phase [50]. Depletion of circHIPK3 in
HEK293T cells has also been shown to supress cell proliferation and is indicative of a role in cellular
growth [32].
6.4. circRNAs in Regulation of Cellular Stress
It is vital for living organisms to maintain homeostasis at the cellular level to sustain viability.
circRNAs have been reported to be involved with cellular homeostasis both positively and negatively,
by regulating aspects of cellular growth, apoptosis, immune-response, and resistance to therapeutics.
CDR1as has been shown to have potential roles in the regulation p21-activated kinase 1 (PAK1),
promoting DNA repair and preventing apoptosis [51]. Mouse embryonic fibroblasts exposed to
reactive oxygen species demonstrate upregulation of circFOXO3, promoting senescence via reducing
nuclear translocation of ID-1, E2F1, and HIF1α and altering the mitochondrial localization of focal
adhesion kinase (FAK), all of which are involved in cellular survival [50]. A circRNA derived from the
DENND4C gene has also been reported to have roles in adaptation to hypoxic conditions in breast
cancer cells [52]. Overexpression of a circRNA produced from the locus encoding the lncRNA ANRIL
has been shown to induce prolonged nucleolar stress in cultured human cells [53]. circRNAs have
also been reported to have roles in macrophage activation and antimicrobial response via positive
regulation of the intracellular adhesion molecule 1 (ICAM1) gene in the Toll-like receptor 4 (TLR4)
pathway [54].
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7. circRNAs in Disease
In accordance with a pivotal role in gene regulation, perturbation of circRNA expression is
beginning to be reported in association with disease. Altered circRNA expression has been reported
in several diseases like cancer, heart disease, neurological disorders, diabetes and atherosclerosis,
although the precise mechanisms by which they operate are yet to be disclosed.
7.1. circRNAs in Cancer
In accordance with their known role in modulating cell cycles, proliferation and cellular senescence
as demonstrated in vitro studies, circRNAs have been implicated in cancer. circRNA hsa_circ_001569
(circABCC) may play a role in modulating gene expression in colorectal cancer by virtue of its action
on miR-145. miR-145 is a negative regulator of target genes such as E2F5, BAG4, and FMNL2
which are known to be involved in the suppression of proliferation [55]. Similarly, CDR1as has
also been implicated in several cancer subtypes including hepatocellular carcinoma (HCC). CDR1as
expression is known to be correlated with hepatic microvascular invasion in HCC tissue [56] and
hsa_circ_0000520 (circRPPH1), hsa_circ_0005075 (circEIF4G3), hsa_circ_0066444 (circADAMTS9), and
hsa_circ_0001649 (circSRPRH) have all been shown to be expressed at different levels in HCC compared
to adjacent normal liver tissues [57,58]. hsa_circ_0005075 (circEIF4G3) correlated with tumour size
while hsa_circ_0001649 (circSRPRH) was downregulated and also correlated with tumour size in
addition to the prevalence of tumour embolus and could be involved in tumorigenesis and metastasis
of HCC [57,58]. circRNA circZKSCAN1 has also been shown to be lower in tumours and correlated
with tumour size in HCC [59].
Large-scale dysregulation of circRNA expression has been noted in bladder carcinoma, where
microarray analysis revealed that 469 circRNA were differentially expressed, 285 showing increased
expression in bladder cancer compared with 184 showing downregulation. Of these, circTCF25
regulates miRNAs miR-103a-3p/miR-107, with circTCF25 upregulation being associated with increased
levels of 13 targets associated with cell proliferation, migration, and invasion in bladder cancer [60].
Similarly, increased expression of circRNA circMYLK in bladder cancer leads to overexpression
of DNMT3B, VEGFA, and ITGB1 genes, which are involved in promotion of proliferation and are
molecular targets of miRNA-29a-3p [61]. circRNA circHIAT1 has also been reported to respond to
signalling through the androgen receptor to promote tumour migration and invasion in clear cell renal
cell carcinoma by enhancement of CDC42 expression through regulation of miR-195-5p/29a-3p and
miR-29c-3p target genes [62]. Recently, fusion-circRNAs (f-circRNA) have been shown to accelerate
proliferation rate and instigate cellular transformation. Furthermore, f-circRNAs f-circM9 and f-circPR
have been shown to confer resistance to therapeutics due to protective effects of drug-induced apoptosis
in cancer cells in vitro via a MAPK/AKT dependent signalling pathway [63].
7.2. circRNAs in Neurological Disease
CDR1as has been associated with neurodegenerative conditions such as Alzheimer’s disease
(AD). In patients with moderate to advanced stages of sporadic AD, CDR1as expression has been
reported to be reduced, which may lead to elevated miR-7 expression and consequent downregulation
of miR-7 dependent mRNAs. One target, ubiquitin protein ligase A, is responsible for the clearance
of amyloid peptides in AD and other degenerative disorders [64]. Although most studies with
circRNAs have been conducted in vitro, recently, Piwecka et al. generated a knockout murine model
for Cdr1as. The brains of these transgenic mice had upregulated expression of miR-7 genes, such as
c-Fos. Cdr1as knockout mice demonstrate impaired synaptic transmission and information processing
defects [33]. circRNAs also have potential roles in memory; circPAIP2 has been suggested to upregulate
memory-related gene PAIP2 through the poly A binding protein (PABP)-associated pathway [65].
A role for circRNAs in major depressive disorder is also suggested by the observation that a significant
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change of hsa_circRNA_103636 expression was noted in patients after eight weeks on antidepressant
therapies [66].
7.3. circRNAs in Osteoarthritis
Osteoarthritis (OA) occurs because of degenerative changes in the joint cartilage. Seventy-one
circRNAs were seen to be differentially expressed in the cartilage of patients with OA compared with
those of non-OA controls. The circRNA circ-CER appears to be of particular importance. circ-CER
expression was shown to increase with increased expression of pro-inflammatory signalling molecules
such as interleukin (IL)-1 and tumour necrosis factor (TNF)α. Suppression of circ-CER resulted in
reduced matrix metalloproteinase-13 (MMP13) expression and remodelling of the extracellular matrix
(ECM). The authors suggest that this observation arises from a sponging effect of circ-CER on miR-136,
which is known to target the MMP13 gene [67].
7.4. circRNAs in Cardiovascular Disease
The CDKN2A/CDKN2B locus expresses an alternatively spliced non-coding transcript, ANRIL,
which encodes a circular form in addition to its linear form. circANRIL has been reported to regulate
the pescadillo homologue 1 (PES1) gene transcript, which is involved in pre-rRNA processing and
ribosome biogenesis. Sequestration of this essential factor and suppression of these key processes
in vascular smooth muscle cells and macrophages was shown to cause nucleolar stress and p53
activation, resulting in apoptosis and features of atherosclerosis [68]. Some circRNAs have been shown
to be protective in heart function; the circRNA heart-related circRNA HRCR has been implicated in
protection from cardiac hypertrophy and heart failure, by virtue of its binding of the inflammatory
onco-miR miR-223 [69,70]. Some RNA inding Motif Protein 20 (RBM20)-dependent circRNAs have
also been reported to be differentially regulated in dilated cardiomyopathy [71]. Similarly, circRNA
MFACR has been shown to sponge miR-652-3p in the cytoplasm, promoting mitochondrial fission and
cardiomyocyte cell death by enhancing translation of MTP18 in animal models [72]. Similarly, high
levels of circRNA_000203 and circRNA_010567 have been reported in cardiomyocytes from diabetic
mice treated with angiotensin II. These circRNAs are thought to downregulate miR-26b-5p, miR-141,
and miR-141, thereby upregulating the TGFB1 gene. This leads to suppression of fibrosis-associated
protein resection in collagen 1 (Col I), collagen 3 (Col III), and α-smooth muscle actin (α-SMA),
promoting fibrosis in the myocardium [73,74].
7.5. circRNAs in Type 2 Diabetes
In addition to the role of CDR1as in regulation of insulin secretion through modulation of
PAX6, recent studies have suggested that circRNAs may have utility as biomarkers of diabetes.
Four hundred eighty-nine circRNAs were found to be differentially expressed in the peripheral blood
of patients with type 2 diabetes, and furthermore, circRNA hsa_circ_0054633 was found to be capable
of predicting pre-diabetes with an area under the curve (AUC) of 0.84 (p ≤ 0.001) [75]. In other studies,
several circRNAs have been shown to be differentially expressed in serum of patients with diabetic
retinopathy compared to that of both controls and diabetes patients without retinopathy. Of these,
hsa_circRNA_100750 is derived from stromal interaction molecule 1 which is upregulated in diabetic
patients. hsa_circRNA_104387 is known to sequester miR-29a which prevents the loss of renal function
in diabetic patients. hsa_circRNA_103410 is known as a regulator of miR-126, which is known to
inhibit VEGF and MMP9 expression. Thus, hsa_circRNA_103410 could promote endothelial injury
in the retina, while hsa_circRNA_100192 could, by sequestering miR-146, promote necrosis factor
(NF)-κB activation, adenosine deaminase-2 expression, and inflammatory responses as is observed
in vitro [76]. These observations raise the exciting possibility that circRNAs expressed in accessible
tissues may be useful markers of disease in inaccessible organs such as pancreas. circHIPK3 has been
found to be dysregulated in diabetic retinas, which may contribute to elevated levels of VEGFC, FZD4,
and WNT2 expression by virtue of its effects on miR-30a-3p [77].
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7.6. circRNAs and Pre-Eclampsia
A study has implicated circRNAs in the development of preeclampsia. Qian et al. identified 143
up-regulated and 158 down-regulated circRNAs in placental tissues from women with pre-eclampsia,
which included upregulated hsa_circRNA_100782 (circHIPK3), hsa_circRNA_102682 (circCRIM1), and
hsa_circRNA_104820 (circFAM120A) circRNAs [78]. Altered circ_101222 expression before 20 weeks
of pregnancy was seen to correlate with higher levels of endoglin, a component of the transforming
growth factor beta (TGFβ) signalling pathway, which is associated with pre-eclampsia, than women
who did not have pre-eclampsia. circRNA circ_101222, in combination with endoglin levels, may
therefore have the potential to predict pre-eclampsia very early on in pregnancies [79].
7.7. circRNAs and Infection
Microbial lipopolysaccharide induces the activation of TLR pathways leading to activation
of NF-κB and modulation of genes which are key to antimicrobial defences and adaptive
immunity. circRasGEF1B has been suggested to modulate the expression of ICAM-1 as part of the
lipopolysaccharide response. Knock down of this circRNA in vitro leads to 27%–39% reduction in
ICAM-1epression in vitro [54]. In mouse macrophage cells, activation of TLR4, TLR9, TLR3, TLR2, and
TLR1 receptors all regulate the expression of circRasGEF1B [54]. Genetically modifying circRasGEF1B
expression was shown to reduce ICAM1 expression levels, which under normal conditions would
promote binding of leukocytes to endothelium cells and their transmigration into target tissues [54].
Thus, deficiency of circRasGEF1B may prevent migration of leukocyte cells to inflammatory sites and
interfere with the healing process, and in cancer cells may additionally affect the activation of cytotoxic
T-lymphocytes needed for driving release of cytolytic granules into tumour cells [54].
A potential role for circRNA in response to viral infection has been reported. HeLa cells transfected
with circRNA demonstrated induced expression of 84 innate immunity-related genes, such as RIGI and
OASl, which were upregulated by as much as 500-fold and 200-fold, respectively [80]. Concurrent with
these changes was a 10-fold decrease in infection rate against Venezuelan equine encephalitis virus,
which was shared by nearby non-transfected cells, indicating some paracrine action [80]. circRNAs can
also act as competitors with viral mitochondrial RNA (mtRNA) for binding to RNA-binding domain
containing immune factor NF90 and its isoform NF110. These factors can promote circularization by
stabilizing the binding of intronic RNA pairs in the nucleus. Viral infection results in transportation of
these factors from the nucleus to the cytoplasm resulting in decreased circRNA expression in infected
cells. This acts to render the circRNA available for binding to viral mRNA and prevents viral infection
of the host cell [81].
7.8. circRNAs in Ageing and Cellular Senescence
circRNAs are known to accumulate in ageing brains [82]. This may be partly due to the
endonuclease-resistant nature of circRNA molecules, but at least two circRNAs have been previously
described to have a role in ageing or cellular senescence. circRNA circPVT1 has been demonstrated to
suppress cellular senescence by sequestration of miRNA let-7, which lifts its inhibitory action on its
target genes IGF2BP1, KRAS, and HMGA2, which act to promote cell proliferation [83]. Conversely,
the circFOXO3 circRNA was found to promote senescence in the heart muscle of aged mice and
humans through its action on the ID1, E2F1, FAK, and HIF1A target genes [9]. This circRNA is also
known to silence cell proliferation through its regulation of the cell division kinase 2 (CDK2) gene and
the cyclin dependent kinase inhibitor p21 [9].
8. circRNAs as Diagnostic and Prognostic Markers
Because circRNAs are highly nuclease-resistant, they are more stable than linear transcripts and
may be released into the extracellular space via the exosomes [12,84]. Half-lives of circRNAs can
vary significantly, but can be as long as 50 h. On average, their half-lives are around 2.5-fold longer
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than the median half-lives of their linear counterparts [85]. A substantial number of circRNAs are
expressed in blood at comparatively higher levels than their linear mRNAs, thus making circRNAs
attractive tools for diagnostics to trace the mechanism of coded genes otherwise inaccessible by
the canonical RNA pathway-dependent assays [86]. A selection of circRNAs reported as potential
biomarkers for different diseases are summarized in Table 1. Over 400 circRNAs have been detected to
be present in cell-free saliva and could potentially be used for non-invasive diagnostics approach [87].
circRNAs have been suggested as potential biomarkers for several types of cancer. In murine
models, tumour-derived exosomal circRNAs in the serum correlate with tumour mass [88], and
thus may be promising biomarkers for cancer detection. circRNA hsa_circ_0001649 (circSHPRH) has
shown some utility as a biomarker for hepatocellular carcinoma, is downregulated with tumour
status, and is associated with the occurrence of the tumour embolus as well as the size of the
tumour [57]. hsa_circ_002059 (circKIAA0907) is downregulated in gastric cancer and is associated
with grade and distal metastasis and could, therefore, be used as a prognostic marker [89]. Another
circRNA, hsa_circ_0000190 (circDYRK1A), is downregulated in plasma samples of patient with gastric
cancer, where its expression levels correlated with tumour diameter, lymphatic metastasis, and distal
metastasis [90]. Similarly, hsa_circ_0001895 (circPRRC2B) was also shown to be downregulated in
gastric cancer tissues and correlated with cell differentiation and Borrmann type [91]. In hepatitis B
infected hepatocellular carcinoma (HCC) patients, circRNA_100338 (circSNX27) has been shown to
regulate levels of miR-141-3p, and its expression correlated with low cumulative survival rate and
metastatic progression [92].
Table 1. Examples of circRNA and their potential role in disease.
circRNA Pathologic Condition Possible Mode of Function Potential Application
hsa_circRNA_062557,
hsa_circRNA_067130,
hsa_circRNA_067209,
hsa_circRNA_100914,
hsa_circRNA_089761,
hsa_circRNA_089763
moyamoya disease
May sequester miRNAs
associated with RNF213 and
BRCA1/BRCA2-containing
complex subunit 3
Potential biomarker expressed in blood [93]
CDR1as hepatocellular carcinoma May be a sponge for miR-7
Biomarker with the ability to predict
hepatic microvascular invasion; expressed
in hepatocellular carcinoma tissues [56]
hsa_circ_0001017, hsa_circ_0061276 gastric cancer
Prognostic, with the ability to predict
disease-free survival; expressed in
plasma [94]
hsa_circ_0089378, hsa_circ_0083357,
hsa_circ_0082824, hsa_circ_0068942,
hsa_circ_0057576, hsa_circ_0054537,
hsa_circ_0051172, hsa_circ_0032970,
hsa_circ_0006323
coronary artery disease
May promote expression of
transient receptor potential
cation channel subfamily
M member 3 by inhibiting
hsa-miR-130a-3p
Potential biomarker expressed in
plasma [95]
GSDMB circRNA multiple sclerosis Potential biomarker expressed in peripheralblood mononuclear cells [96]
hsa_circRNA_105055,
hsa_circRNA_086376,
hsa_circRNA_102761
colorectal cancer
May act as sponge for miR-7
regulating target genes PRKCB,
EPHA3, BRCA1, and ABCC1;
potential role in lung metastasis
Potential biomarker [97]
hsa_circ_0092285, hsa_circ_0058794,
hsa_circ_0088088, hsa_circ_0038644 rheumatoid arthritis
May be involved in response to
oxidative stress; endocytic traffic
in actin cytoskeleton; could
promote lipid breakdown and
increase free fatty acid levels;
could alter lipopolysacccharide
(LPS) immune response
Potential biomarker expressed in peripheral
blood mononuclear cells [98]
hsa_circRNA_101308,
hsa_circRNA_104423,
hsa_circRNA_104916,
hsa_circRNA_100269
gastric cancer
May predict the early recurrence of stage III
gastric cancer after radical surgery;
expressed in tumour tissues [99]
circPVT1 gastric cancer
May act as sponge for
miR-125 family; may promote
cell proliferation
Potential prognostic marker with the ability
to predict overall survival and disease-free
survival; expressed in gastric cancer
tissues [100]
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Table 1. Cont.
circRNA Pathologic Condition Possible Mode of Function Potential Application
circRNA_104871, circRNA_003524,
circRNA_101873, circRNA_103047 rheumatoid arthritis
Potential biomarker expressed in peripheral
blood mononuclear cells [101]
hsa_circ_0058246 gastric cancer
Potential prognostic marker with the ability
to predict clinical outcome; expressed in
tumour tissues [102]
circ-ITCH hepatocellular carcinoma May inhibit Wnt/β-Cateninpathway
Potential prognostic marker with the ability
to predict survival; expressed in
hepatocellular carcinoma tissues [103]
hsa-circ-0005870 hypertension
May act as sponge for miRNAs,
hsa-miR-6807-3p, hsa-miR-5095,
hsa-miR-1273g-3p,
hsa-miR-5096, and
hsa-miR-619-5p, possibly
affecting transforming growth
factor beta (TGF-beta) pathway
important in hypertension
Potential biomarker expressed in
plasma [104]
hsa_circ_0124644, coronary artery disease Potential diagnostic biomarker; expressedin blood [105]
circR-284 carotid disease andischemic stroke
May act as an inhibitor of
miR-221/miR-222
Potential diagnostic biomarker:expression
demonstrated in serum [106]
circ_0005402, circ_0035560 multiple sclerosis Potential biomarker; expressed inleucocytes [107]
circZKSCAN1 hepatocellular carcinoma
May modulate expression of
apoptotic genes RAC2, EFNA3,
and caspase 3 and cell
proliferation related genes
TGFB1, ITGB4, CXCR4, BIRC5,
and CCND1; may modulate
promoted cell proliferation,
migration, and invasion in vitro
Expressed in tumour tissues [59]
circ_101222 pre-eclampsia Potential biomarker; expressed inblood [79]
hsa_circ_0054633 diabetes
Potential biomarker with the ability to
predict pre-diabetes and type 2 diabetic
status; expressed in blood [75]
9. Conclusions
circRNAs are a class of non-coding RNAs which appear to regulate the expression of genes by
a variety of mechanisms and might also have the potential of encoding proteins, the mechanisms of
which are not yet completely understood. Despite this, circRNAs are emerging as potentially important
regulators of cellular physiology and as potential biomarkers of disease onset or progression. The state
of the current knowledge of circRNA biology is as yet at a very early stage, and further research is
urgently required to completely understand their function and potential. Despite this, it is likely that
these novel circRNAs will emerge as important players in gene regulation in the future. The origin of
circRNAs from throughout the genome raises the possibility of co-ordinated regulation of modules of
genes in a cell, tissue, and developmental stage specific pattern, adding another level of regulation
to the already complex field of non-coding RNA (ncRNA) regulation of gene expression. In future
years, circRNAs could be exploited as therapeutics. Over-expression of specific circRNA constructs
could act to modulate cell behaviour and physiology by sponging oncogenic miRNAs such as miR-21
and miR-221 in cancer cells [108]. Antisense approaches such as morpholino technologies to influence
splicing patterns are already in development for diseases such as Duchenne muscular dystrophy [109]
and could in theory be developed to target exons that may be circularized to bring about higher
expression of beneficial circRNAs once their modes of action have been elucidated.
Acknowledgments: The Harries lab is funded by the Dunhill Medical Trust and Animal Free Research.
Author Contributions: S.H. researched and wrote this review, L.W.H. reviewed and edited this work.
Conflicts of Interest: The authors declare no conflict of interest.
Genes 2017, 8, 353 12 of 17
References
1. Danan, M.; Schwartz, S.; Edelheit, S.; Sorek, R. Transcriptome-wide discovery of circular RNAs in Archaea.
Nucleic Acids Res. 2012, 40, 3131–3142. [CrossRef] [PubMed]
2. Jeck, W.R.; Sorrentino, J.A.; Wang, K.; Slevin, M.K.; Burd, C.E.; Liu, J.; Marzluff, W.F.; Sharpless, N.E. Circular
RNAs are abundant, conserved, and associated with ALU repeats. RNA 2013, 19, 141–157. [CrossRef]
[PubMed]
3. Nigro, J.M.; Cho, K.R.; Fearon, E.R.; Kern, S.E.; Ruppert, J.M.; Oliner, J.D.; Kinzler, K.W.; Vogelstein, B.
Scrambled exons. Cell 1991, 64, 607–613. [CrossRef]
4. Salzman, J.; Chen, R.E.; Olsen, M.N.; Wang, P.L.; Brown, P.O. Cell-type specific features of circular RNA
expression. PLoS Genet. 2013, 9, e1003777. [CrossRef]
5. Lan, P.H.; Liu, Z.H.; Pei, Y.J.; Wu, Z.G.; Yu, Y.; Yang, Y.F.; Liu, X.; Che, L.; Ma, C.J.; Xie, Y.K.; et al. Landscape
of RNAs in human lumbar disc degeneration. Oncotarget 2016, 7, 63166–63176. [CrossRef] [PubMed]
6. Legnini, I.; Di Timoteo, G.; Rossi, F.; Morlando, M.; Briganti, F.; Sthandier, O.; Fatica, A.; Santini, T.;
Andronache, A.; Wade, M.; et al. Circ-ZNF609 Is a Circular RNA that Can Be Translated and Functions in
Myogenesis. Mol. Cell 2017, 66, 22. [CrossRef] [PubMed]
7. Veno, M.T.; Hansen, T.B.; Veno, S.T.; Clausen, B.H.; Grebing, M.; Finsen, B.; Holm, I.E.; Kjems, J.
Spatio-temporal regulation of circular RNA expression during porcine embryonic brain development.
Genome Biol. 2015, 16, 245. [CrossRef] [PubMed]
8. Barrett, S.P.; Salzman, J. Circular RNAs: Analysis, expression and potential functions. Development 2016, 143,
1838–1847. [CrossRef] [PubMed]
9. Du, W.W.; Yang, W.; Liu, E.; Yang, Z.; Dhaliwal, P.; Yang, B.B. Foxo3 circular RNA retards cell cycle
progression via forming ternary complexes with p21 and CDK2. Nucleic Acids Res. 2016, 44, 2846–2858.
[CrossRef] [PubMed]
10. Cocquerelle, C.; Mascrez, B.; Hetuin, D.; Bailleul, B. Mis-splicing yields circular RNA molecules. FASEB J.
1993, 7, 155–160. [PubMed]
11. Schwanhausser, B.; Busse, D.; Li, N.; Dittmar, G.; Schuchhardt, J.; Wolf, J.; Chen, W.; Selbach, M. Global
quantification of mammalian gene expression control. Nature 2011, 473, 337–342. [CrossRef] [PubMed]
12. Lasda, E.; Parker, R. Circular RNAs Co-Precipitate with Extracellular Vesicles: A Possible Mechanism for
circRNA Clearance. PLoS ONE 2016, 11, e0148407. [CrossRef] [PubMed]
13. Kramer, M.C.; Liang, D.; Tatomer, D.C.; Gold, B.; March, Z.M.; Cherry, S.; Wilusz, J.E. Combinatorial control
of Drosophila circular RNA expression by intronic repeats, hnRNPs, and SR proteins. Genes Dev. 2015, 29,
2168–2182. [CrossRef] [PubMed]
14. Ivanov, A.; Memczak, S.; Wyler, E.; Torti, F.; Porath, H.T.; Orejuela, M.R.; Piechotta, M.; Levanon, E.Y.;
Landthaler, M.; Dieterich, C.; et al. Analysis of Intron Sequences Reveals Hallmarks of Circular RNA
Biogenesis in Animals. Cell Rep. 2015, 10, 170–177. [CrossRef] [PubMed]
15. Salzman, J.; Gawad, C.; Wang, P.L.; Lacayo, N.; Brown, P.O. Circular RNAs are the predominant transcript
isoform from hundreds of human genes in diverse cell types. PLoS ONE 2012, 7, e30733. [CrossRef] [PubMed]
16. Starke, S.; Jost, I.; Rossbach, O.; Schneider, T.; Schreiner, S.; Hung, L.H.; Bindereif, A. Exon Circularization
Requires Canonical Splice Signals. Cell Rep. 2015, 10, 103–111. [CrossRef] [PubMed]
17. Liang, D.M.; Wilusz, J.E. Short intronic repeat sequences facilitate circular RNA production. Gene Dev. 2014,
28, 2233–2247. [CrossRef] [PubMed]
18. Ashwal-Fluss, R.; Meyer, M.; Pamudurti, N.R.; Ivanov, A.; Bartok, O.; Hanan, M.; Evantal, N.; Memczak, S.;
Rajewsky, N.; Kadener, S. circRNA biogenesis competes with pre-mRNA splicing. Mol. Cell 2014, 56, 55–66.
[CrossRef] [PubMed]
19. Conn, S.J.; Pillman, K.A.; Toubia, J.; Conn, V.M.; Salmanidis, M.; Phillips, C.A.; Roslan, S.; Schreiber, A.W.;
Gregory, P.A.; Goodall, G.J. The RNA binding protein quaking regulates formation of circRNAs. Cell 2015,
160, 1125–1134. [CrossRef] [PubMed]
20. Zhang, Y.; Xue, W.; Li, X.; Zhang, J.; Chen, S.; Zhang, J.L.; Yang, L.; Chen, L.L. The Biogenesis of Nascent
Circular RNAs. Cell Rep. 2016, 15, 611–624. [CrossRef] [PubMed]
21. Zhang, Y.; Zhang, X.O.; Chen, T.; Xiang, J.F.; Yin, Q.F.; Xing, Y.H.; Zhu, S.; Yang, L.; Chen, L.L. Circular
intronic long noncoding RNAs. Mol. Cell 2013, 51, 792–806. [CrossRef] [PubMed]
Genes 2017, 8, 353 13 of 17
22. Chen, I.; Chen, C.Y.; Chuang, T.J. Biogenesis, identification, and function of exonic circular RNAs.
Wiley Interdiscip. Rev. RNA 2015, 6, 563–579. [CrossRef] [PubMed]
23. Meng, X.; Li, X.; Zhang, P.; Wang, J.; Zhou, Y.; Chen, M. Circular RNA: An emerging key player in RNA
world. Brief. Bioinform. 2017, 18, 547–557. [CrossRef] [PubMed]
24. Jeck, W.R.; Sharpless, N.E. Detecting and characterizing circular RNAs. Nat. Biotechnol. 2014, 32, 453–461.
[CrossRef] [PubMed]
25. Hansen, T.B.; Veno, M.T.; Damgaard, C.K.; Kjems, J. Comparison of circular RNA prediction tools.
Nucleic Acids Res. 2016, 44, e58. [CrossRef] [PubMed]
26. Glazar, P.; Papavasileiou, P.; Rajewsky, N. circBase: A database for circular RNAs. RNA 2014, 20, 1666–1670.
[CrossRef] [PubMed]
27. van Rossum, D.; Verheijen, B.M.; Pasterkamp, R.J. Circular RNAs: Novel Regulators of Neuronal
Development. Front. Mol. Neurosci. 2016, 9, 74. [CrossRef] [PubMed]
28. Tay, Y.; Rinn, J.; Pandolfi, P.P. The multilayered complexity of ceRNA crosstalk and competition. Nature 2014,
505, 344–352. [CrossRef] [PubMed]
29. Memczak, S.; Jens, M.; Elefsinioti, A.; Torti, F.; Krueger, J.; Rybak, A.; Maier, L.; Mackowiak, S.D.;
Gregersen, L.H.; Munschauer, M.; et al. Circular RNAs are a large class of animal RNAs with regulatory
potency. Nature 2013, 495, 333–338. [CrossRef] [PubMed]
30. Hansen, T.B.; Jensen, T.I.; Clausen, B.H.; Bramsen, J.B.; Finsen, B.; Damgaard, C.K.; Kjems, J. Natural RNA
circles function as efficient microRNA sponges. Nature 2013, 495, 384–388. [CrossRef] [PubMed]
31. Guo, J.U.; Agarwal, V.; Guo, H.L.; Bartel, D.P. Expanded identification and characterization of mammalian
circular RNAs. Genome Biol. 2014, 15. [CrossRef] [PubMed]
32. Zheng, Q.; Bao, C.; Guo, W.; Li, S.; Chen, J.; Chen, B.; Luo, Y.; Lyu, D.; Li, Y.; Shi, G.; et al. Circular
RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs.
Nat. Commun. 2016, 7. [CrossRef] [PubMed]
33. Piwecka, M.; Glazar, P.; Hernandez-Miranda, L.R.; Memczak, S.; Wolf, S.A.; Rybak-Wolf, A.; Filipchyk, A.;
Klironomos, F.; Cerda Jara, C.A.; Fenske, P.; et al. Loss of a mammalian circular RNA locus causes miRNA
deregulation and affects brain function. Science 2017, 357. [CrossRef] [PubMed]
34. Hansen, T.B.; Wiklund, E.D.; Bramsen, J.B.; Villadsen, S.B.; Statham, A.L.; Clark, S.J.; Kjems, J.
miRNA-dependent gene silencing involving Ago2-mediated cleavage of a circular antisense RNA. EMBO J.
2011, 30, 4414–4422. [CrossRef] [PubMed]
35. Li, Z.; Huang, C.; Bao, C.; Chen, L.; Lin, M.; Wang, X.; Zhong, G.; Yu, B.; Hu, W.; Dai, L.; et al. Exon-intron
circular RNAs regulate transcription in the nucleus. Nat. Struct. Mol. Biol. 2015, 22, 256–264. [CrossRef]
[PubMed]
36. Grigull, J.; Mnaimneh, S.; Pootoolal, J.; Robinson, M.D.; Hughes, T.R. Genome-wide analysis of mRNA
stability using transcription inhibitors and microarrays reveals posttranscriptional control of ribosome
biogenesis factors. Mol. Cell. Biol. 2004, 24, 5534–5547. [CrossRef] [PubMed]
37. Gualandi, F.; Trabanelli, C.; Rimessi, P.; Calzolari, E.; Toffolatti, L.; Patarnello, T.; Kunz, G.; Muntoni, F.;
Ferlini, A. Multiple exon skipping and RNA circularisation contribute to the severe phenotypic expression
of exon 5 dystrophin deletion. J. Med. Genet. 2003, 40, e100. [CrossRef] [PubMed]
38. Chao, C.W.; Chan, D.C.; Kuo, A.; Leder, P. The mouse formin (Fmn) gene: Abundant circular RNA transcripts
and gene-targeted deletion analysis. Mol. Med. 1998, 4, 614–628. [PubMed]
39. Abdelmohsen, K.; Panda, A.C.; Munk, R.; Grammatikakis, I.; Dudekula, D.B.; De, S.; Kim, J.; Noh, J.H.;
Kim, K.M.; Martindale, J.L.; et al. Identification of HuR target circular RNAs uncovers suppression of
PABPN1 translation by circPABPN1. RNA Biol. 2017, 14, 361–369. [CrossRef] [PubMed]
40. Conn, V.M.; Hugouvieux, V.; Nayak, A.; Conos, S.A.; Capovilla, G.; Cildir, G.; Jourdain, A.; Tergaonkar, V.;
Schmid, M.; Zubieta, C.; et al. A circRNA from SEPALLATA3 regulates splicing of its cognate mRNA through
R-loop formation. Nat. Plants 2017, 3, 17053. [CrossRef] [PubMed]
41. Pamudurti, N.R.; Bartok, O.; Jens, M.; Ashwal-Fluss, R.; Stottmeister, C.; Ruhe, L.; Hanan, M.; Wyler, E.;
Perez-Hernandez, D.; Ramberger, E.; et al. Translation of circRNAs. Mol. Cell 2017, 66, 9–21. [CrossRef]
[PubMed]
42. Yang, Y.; Gao, X.; Zhang, M.; Yan, S.; Sun, C.; Xiao, F.; Huang, N.; Yang, X.; Zhao, K.; Zhou, H.; et al. Novel
Role of FBXW7 Circular RNA in Repressing Glioma Tumorigenesis. J. Natl. Cancer Inst. 2018, 110. [CrossRef]
[PubMed]
Genes 2017, 8, 353 14 of 17
43. Yang, Y.; Fan, X.; Mao, M.; Song, X.; Wu, P.; Zhang, Y.; Jin, Y.; Yang, Y.; Chen, L.L.; Wang, Y.; et al. Extensive
translation of circular RNAs driven by N6-methyladenosine. Cell Res. 2017, 27, 626–641. [CrossRef] [PubMed]
44. Xia, S.; Feng, J.; Lei, L.; Hu, J.; Xia, L.; Wang, J.; Xiang, Y.; Liu, L.; Zhong, S.; Han, L.; et al. Comprehensive
characterization of tissue-specific circular RNAs in the human and mouse genomes. Brief. Bioinform. 2016.
[CrossRef] [PubMed]
45. You, X.; Vlatkovic, I.; Babic, A.; Will, T.; Epstein, I.; Tushev, G.; Akbalik, G.; Wang, M.; Glock, C.; Quedenau, C.;
et al. Neural circular RNAs are derived from synaptic genes and regulated by development and plasticity.
Nat. Neurosci. 2015, 18, 603–610. [CrossRef] [PubMed]
46. Foster, J.W.; Brennan, F.E.; Hampikian, G.K.; Goodfellow, P.N.; Sinclair, A.H.; Lovell-Badge, R.; Selwood, L.;
Renfree, M.B.; Cooper, D.W.; Graves, J.A. Evolution of sex determination and the Y chromosome: SRY-related
sequences in marsupials. Nature 1992, 359, 531–533. [CrossRef] [PubMed]
47. Hawkins, J.R.; Taylor, A.; Berta, P.; Levilliers, J.; Van der Auwera, B.; Goodfellow, P.N. Mutational analysis
of SRY: nonsense and missense mutations in XY sex reversal. Hum. Genet. 1992, 88, 471–474. [CrossRef]
[PubMed]
48. Xu, H.; Guo, S.; Li, W.; Yu, P. The circular RNA Cdr1as, via miR-7 and its targets, regulates insulin transcription
and secretion in islet cells. Sci. Rep. 2015, 5, 12453. [CrossRef] [PubMed]
49. Wang, Y.; Liu, J.; Liu, C.; Naji, A.; Stoffers, D.A. microRNA-7 regulates the mTOR pathway and proliferation
in adult pancreatic beta-cells. Diabetes 2013, 62, 887–895. [CrossRef] [PubMed]
50. Du, W.W.; Yang, W.; Chen, Y.; Wu, Z.K.; Foster, F.S.; Yang, Z.; Li, X.; Yang, B.B. Foxo3 circular RNA
promotes cardiac senescence by modulating multiple factors associated with stress and senescence responses.
Eur. Heart J. 2016. [CrossRef] [PubMed]
51. Bachmayr-Heyda, A.; Reiner, A.T.; Auer, K.; Sukhbaatar, N.; Aust, S.; Bachleitner-Hofmann, T.; Mesteri, I.;
Grunt, T.W.; Zeillinger, R.; Pils, D. Correlation of circular RNA abundance with proliferation–exemplified
with colorectal and ovarian cancer, idiopathic lung fibrosis, and normal human tissues. Sci. Rep. 2015, 5,
8057. [CrossRef] [PubMed]
52. Liang, G.; Liu, Z.; Tan, L.; Su, A.N.; Jiang, W.G.; Gong, C. HIF1alpha-associated circDENND4C Promotes
Proliferation of Breast Cancer Cells in Hypoxic Environment. Anticancer Res. 2017, 37, 4337–4343. [CrossRef]
[PubMed]
53. Burd, C.E.; Jeck, W.R.; Liu, Y.; Sanoff, H.K.; Wang, Z.; Sharpless, N.E. Expression of linear and novel circular
forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk. PLoS Genet. 2010, 6,
e1001233. [CrossRef] [PubMed]
54. Ng, W.L.; Marinov, G.K.; Liau, E.S.; Lam, Y.L.; Lim, Y.Y.; Ea, C.K. Inducible RasGEF1B circular RNA is a
positive regulator of ICAM-1 in the TLR4/LPS pathway. RNA Biol. 2016, 13, 861–871. [CrossRef] [PubMed]
55. Xie, H.; Ren, X.; Xin, S.; Lan, X.; Lu, G.; Lin, Y.; Yang, S.; Zeng, Z.; Liao, W.; Ding, Y.Q.; et al. Emerging roles
of circRNA_001569 targeting miR-145 in the proliferation and invasion of colorectal cancer. Oncotarget 2016,
7, 26680–26691. [CrossRef] [PubMed]
56. Xu, L.; Zhang, M.; Zheng, X.B.; Yi, P.S.; Lan, C.; Xu, M.Q. The circular RNA ciRS-7 (Cdr1as) acts as a risk
factor of hepatic microvascular invasion in hepatocellular carcinoma. J. Cancer Res. Clin. Oncol. 2017, 143,
17–27. [CrossRef] [PubMed]
57. Qin, M.; Liu, G.; Huo, X.; Tao, X.; Sun, X.; Ge, Z.; Yang, J.; Fan, J.; Liu, L.; Qin, W. hsa_circ_0001649: A circular
RNA and potential novel biomarker for hepatocellular carcinoma. Cancer Biomark. Sect. Dis. Markers 2016,
16, 161–169. [CrossRef] [PubMed]
58. Shang, X.; Li, G.; Liu, H.; Li, T.; Liu, J.; Zhao, Q.; Wang, C. Comprehensive Circular RNA Profiling
Reveals That hsa_circ_0005075, a New Circular RNA Biomarker, Is Involved in Hepatocellular Crcinoma
Development. Medicine 2016, 95, e3811. [CrossRef] [PubMed]
59. Yao, Z.; Luo, J.; Hu, K.; Lin, J.; Huang, H.; Wang, Q.; Zhang, P.; Xiong, Z.; He, C.; Huang, Z.; et al.
ZKSCAN1 gene and its related circular RNA (circZKSCAN1) both inhibit hepatocellular carcinoma cell
growth, migration, and invasion but through different signaling pathways. Mol. Oncol. 2017, 11, 422–437.
[CrossRef] [PubMed]
60. Zhong, Z.; Lv, M.; Chen, J. Screening differential circular RNA expression profiles reveals the regulatory
role of circTCF25-miR-103a-3p/miR-107-CDK6 pathway in bladder carcinoma. Sci. Rep. 2016, 6, 30919.
[CrossRef] [PubMed]
Genes 2017, 8, 353 15 of 17
61. Huang, M.; Zhong, Z.; Lv, M.; Shu, J.; Tian, Q.; Chen, J. Comprehensive analysis of differentially expressed
profiles of lncRNAs and circRNAs with associated co-expression and ceRNA networks in bladder carcinoma.
Oncotarget 2016, 7, 47186–47200. [CrossRef] [PubMed]
62. Wang, K.; Sun, Y.; Tao, W.; Fei, X.; Chang, C. Androgen receptor (AR) promotes clear cell renal cell carcinoma
(ccRCC) migration and invasion via altering the circHIAT1/miR-195-5p/29a-3p/29c-3p/CDC42 signals.
Cancer Lett. 2017, 394, 1–12. [CrossRef] [PubMed]
63. Guarnerio, J.; Bezzi, M.; Jeong, J.C.; Paffenholz, S.V.; Berry, K.; Naldini, M.M.; Lo-Coco, F.; Tay, Y.;
Beck, A.H.; Pandolfi, P.P. Oncogenic Role of Fusion-circRNAs Derived from Cancer-Associated Chromosomal
Translocations. Cell 2016, 165, 289–302. [CrossRef] [PubMed]
64. Lukiw, W.J. Circular RNA (circRNA) in Alzheimer’s disease (AD). Front. Genet. 2013, 4, 307. [CrossRef]
[PubMed]
65. Khoutorsky, A.; Yanagiya, A.; Gkogkas, C.G.; Fabian, M.R.; Prager-Khoutorsky, M.; Cao, R.; Gamache, K.;
Bouthiette, F.; Parsyan, A.; Sorge, R.E.; et al. Control of synaptic plasticity and memory via suppression of
poly(A)-binding protein. Neuron 2013, 78, 298–311. [CrossRef] [PubMed]
66. Cui, X.; Niu, W.; Kong, L.; He, M.; Jiang, K.; Chen, S.; Zhong, A.; Li, W.; Lu, J.; Zhang, L. hsa_circRNA_103636:
Potential novel diagnostic and therapeutic biomarker in major depressive disorder. Biomark. Med. 2016, 10,
943–952. [CrossRef] [PubMed]
67. Liu, Q.; Zhang, X.; Hu, X.; Dai, L.; Fu, X.; Zhang, J.; Ao, Y. Circular RNA Related to the Chondrocyte ECM
Regulates MMP13 Expression by Functioning as a miR-136 ‘Sponge’ in Human Cartilage Degradation.
Sci. Rep. 2016, 6, 22572. [CrossRef] [PubMed]
68. Holdt, L.M.; Stahringer, A.; Sass, K.; Pichler, G.; Kulak, N.A.; Wilfert, W.; Kohlmaier, A.; Herbst, A.;
Northoff, B.H.; Nicolaou, A.; et al. Circular non-coding RNA ANRIL modulates ribosomal RNA maturation
and atherosclerosis in humans. Nat. Commun. 2016, 7, 12429. [CrossRef] [PubMed]
69. Taibi, F.; Metzinger-Le Meuth, V.; Massy, Z.A.; Metzinger, L. miR-223: An inflammatory oncomiR enters the
cardiovascular field. Biochim. Biophys. Acta 2014, 1842, 1001–1009. [CrossRef] [PubMed]
70. Wang, K.; Long, B.; Liu, F.; Wang, J.X.; Liu, C.Y.; Zhao, B.; Zhou, L.Y.; Sun, T.; Wang, M.; Yu, T.; et al. A circular
RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223. Eur. Heart J.
2016, 37, 2602–2611. [CrossRef] [PubMed]
71. Khan, M.A.; Reckman, Y.J.; Aufiero, S.; van den Hoogenhof, M.M.; van der Made, I.; Beqqali, A.;
Koolbergen, D.R.; Rasmussen, T.B.; van der Velden, J.; Creemers, E.E.; et al. RBM20 Regulates Circular RNA
Production From the Titin Gene. Circ. Res. 2016, 119, 996–1003. [CrossRef] [PubMed]
72. Wang, K.; Gan, T.Y.; Li, N.; Liu, C.Y.; Zhou, L.Y.; Gao, J.N.; Chen, C.; Yan, K.W.; Ponnusamy, M.; Zhang, Y.H.;
et al. Circular RNA mediates cardiomyocyte death via miRNA-dependent upregulation of MTP18 expression.
Cell Death Differ. 2017, 24, 1111–1120. [CrossRef] [PubMed]
73. Tang, C.M.; Zhang, M.; Huang, L.; Hu, Z.Q.; Zhu, J.N.; Xiao, Z.; Zhang, Z.; Lin, Q.X.; Zheng, X.L.; Yang, M.;
et al. circRNA_000203 enhances the expression of fibrosis-associated genes by derepressing targets of
miR-26b-5p, Col1a2 and CTGF, in cardiac fibroblasts. Sci. Rep. 2017, 7, 40342. [CrossRef] [PubMed]
74. Zhou, B.; Yu, J.W. A novel identified circular RNA, circRNA_010567, promotes myocardial fibrosis via
suppressing miR-141 by targeting TGF-beta1. Biochem. Biophys. Res. Commun. 2017, 487, 769–775. [CrossRef]
[PubMed]
75. Zhao, Z.; Li, X.; Jian, D.; Hao, P.; Rao, L.; Li, M. hsa_circ_0054633 in peripheral blood can be used as a
diagnostic biomarker of pre-diabetes and type 2 diabetes mellitus. Acta Diabetol. 2017, 54, 237–245. [CrossRef]
[PubMed]
76. Gu, Y.; Ke, G.; Wang, L.; Zhou, E.; Zhu, K.; Wei, Y. Altered Expression Profile of Circular RNAs in the Serum
of Patients with Diabetic Retinopathy Revealed by Microarray. Ophthalmic Res. 2017, 58, 176–184. [CrossRef]
[PubMed]
77. Shan, K.; Liu, C.; Liu, B.H.; Chen, X.; Dong, R.; Liu, X.; Zhang, Y.Y.; Liu, B.; Zhang, S.J.; Wang, J.J.; et al.
Circular Non-Coding RNA HIPK3 Mediates Retinal Vascular Dysfunction in Diabetes Mellitus. Circulation
2017. [CrossRef] [PubMed]
78. Qian, Y.; Lu, Y.; Rui, C.; Qian, Y.; Cai, M.; Jia, R. Potential Significance of Circular RNA in Human Placental
Tissue for Patients with Preeclampsia. Cell. Phys. Biochem. 2016, 39, 1380–1390. [CrossRef] [PubMed]
Genes 2017, 8, 353 16 of 17
79. Zhang, Y.G.; Yang, H.L.; Long, Y.; Li, W.L. Circular RNA in blood corpuscles combined with plasma protein
factor for early prediction of pre-eclampsia. BJOG Int. J. Obstet. Gynaecol. 2016, 123, 2113–2118. [CrossRef]
[PubMed]
80. Chen, Y.G.; Kim, M.V.; Chen, X.; Batista, P.J.; Aoyama, S.; Wilusz, J.E.; Iwasaki, A.; Chang, H.Y. Sensing Self
and Foreign Circular RNAs by Intron Identity. Mol. Cell 2017, 67, 228–238. [CrossRef] [PubMed]
81. Li, X.; Liu, C.X.; Xue, W.; Zhang, Y.; Jiang, S.; Yin, Q.F.; Wei, J.; Yao, R.W.; Yang, L.; Chen, L.L. Coordinated
circRNA Biogenesis and Function with NF90/NF110 in Viral Infection. Mol. Cell 2017, 67, 214–227. [CrossRef]
[PubMed]
82. Gruner, H.; Cortes-Lopez, M.; Cooper, D.A.; Bauer, M.; Miura, P. circRNA accumulation in the aging mouse
brain. Sci. Rep. 2016, 6, 38907. [CrossRef] [PubMed]
83. Panda, A.C.; Grammatikakis, I.; Kim, K.M.; De, S.; Martindale, J.L.; Munk, R.; Yang, X.; Abdelmohsen, K.;
Gorospe, M. Identification of senescence-associated circular RNAs (SAC-RNAs) reveals senescence
suppressor circPVT1. Nucleic Acids Res. 2017, 45, 4021–4035. [CrossRef] [PubMed]
84. Suzuki, H.; Zuo, Y.; Wang, J.; Zhang, M.Q.; Malhotra, A.; Mayeda, A. Characterization of RNase R-digested
cellular RNA source that consists of lariat and circular RNAs from pre-mRNA splicing. Nucleic Acids Res.
2006, 34, e63. [CrossRef] [PubMed]
85. Enuka, Y.; Lauriola, M.; Feldman, M.E.; Sas-Chen, A.; Ulitsky, I.; Yarden, Y. Circular RNAs are long-lived and
display only minimal early alterations in response to a growth factor. Nucleic Acids Res. 2016, 44, 1370–1383.
[CrossRef] [PubMed]
86. Memczak, S.; Papavasileiou, P.; Peters, O.; Rajewsky, N. Identification and Characterization of Circular
RNAs As a New Class of Putative Biomarkers in Human Blood. PLoS ONE 2015, 10, e0141214. [CrossRef]
[PubMed]
87. Bahn, J.H.; Zhang, Q.; Li, F.; Chan, T.M.; Lin, X.; Kim, Y.; Wong, D.T.; Xiao, X. The landscape of microRNA,
Piwi-interacting RNA, and circular RNA in human saliva. Clin. Chem. 2015, 61, 221–230. [CrossRef]
[PubMed]
88. Li, Y.; Zheng, Q.; Bao, C.; Li, S.; Guo, W.; Zhao, J.; Chen, D.; Gu, J.; He, X.; Huang, S. Circular RNA is enriched
and stable in exosomes: A promising biomarker for cancer diagnosis. Cell Res. 2015, 25, 981–984. [CrossRef]
[PubMed]
89. Li, P.; Chen, S.; Chen, H.; Mo, X.; Li, T.; Shao, Y.; Xiao, B.; Guo, J. Using circular RNA as a novel type of
biomarker in the screening of gastric cancer. Clin. Chim. Acta 2015, 444, 132–136. [CrossRef] [PubMed]
90. Chen, S.; Li, T.; Zhao, Q.; Xiao, B.; Guo, J. Using circular RNA hsa_circ_0000190 as a new biomarker in the
diagnosis of gastric cancer. Clin. Chim. Acta 2017, 466, 167–171. [CrossRef] [PubMed]
91. Shao, Y.; Chen, L.; Lu, R.; Zhang, X.; Xiao, B.; Ye, G.; Guo, J. Decreased expression of hsa_circ_0001895 in
human gastric cancer and its clinical significances. Tumour Biol. 2017, 39, 1010428317699125. [CrossRef]
[PubMed]
92. Huang, X.Y.; Huang, Z.L.; Xu, Y.H.; Zheng, Q.; Chen, Z.; Song, W.; Zhou, J.; Tang, Z.Y.; Huang, X.Y.
Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-100338/miR-141-3p
pathway in hepatitis B-related hepatocellular carcinoma. Sci. Rep. 2017, 7, 5428. [CrossRef] [PubMed]
93. Zhao, M.; Gao, F.; Zhang, D.; Wang, S.; Zhang, Y.; Wang, R.; Zhao, J. Altered expression of circular RNAs in
Moyamoya disease. J. Neurol. Sci. 2017, 381, 25–31. [CrossRef] [PubMed]
94. Li, T.; Shao, Y.; Fu, L.; Xie, Y.; Zhu, L.; Sun, W.; Yu, R.; Xiao, B.; Guo, J. Plasma circular RNA profiling
of patients with gastric cancer and their droplet digital RT-PCR detection. J Mol. Med. 2017. [CrossRef]
[PubMed]
95. Pan, R.Y.; Liu, P.; Zhou, H.T.; Sun, W.X.; Song, J.; Shu, J.; Cui, G.J.; Yang, Z.J.; Jia, E.Z. Circular RNAs promote
TRPM3 expression by inhibiting hsa-miR-130a-3p in coronary artery disease patients. Oncotarget 2017, 8,
60280–60290. [CrossRef] [PubMed]
96. Cardamone, G.; Paraboschi, E.M.; Rimoldi, V.; Duga, S.; Solda, G.; Asselta, R. The Characterization of GSDMB
Splicing and Backsplicing Profiles Identifies Novel Isoforms and a Circular RNA That Are Dysregulated in
Multiple Sclerosis. Int. J. Mol. Sci. 2017, 18. [CrossRef] [PubMed]
97. Zeng, Y.; Xu, Y.; Shu, R.; Sun, L.; Tian, Y.; Shi, C.; Zheng, Z.; Wang, K.; Luo, H. Altered expression profiles
of circular RNA in colorectal cancer tissues from patients with lung metastasis. Int. J. Mol. Med. 2017, 40,
1818–1828. [CrossRef] [PubMed]
Genes 2017, 8, 353 17 of 17
98. Zheng, F.; Yu, X.; Huang, J.; Dai, Y. Circular RNA expression profiles of peripheral blood mononuclear cells
in rheumatoid arthritis patients, based on microarray chip technology. Mol. Med. Rep. 2017, 16, 8029–8036.
[CrossRef] [PubMed]
99. Zhang, Y.; Li, J.; Yu, J.; Liu, H.; Shen, Z.; Ye, G.; Mou, T.; Qi, X.; Li, G. Circular RNAs signature predicts the
early recurrence of stage III gastric cancer after radical surgery. Oncotarget 2017, 8, 22936–22943. [CrossRef]
[PubMed]
100. Chen, J.; Li, Y.; Zheng, Q.; Bao, C.; He, J.; Chen, B.; Lyu, D.; Zheng, B.; Xu, Y.; Long, Z.; et al. Circular RNA
profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer. Cancer Lett. 2017,
388, 208–219. [CrossRef] [PubMed]
101. Ouyang, Q.; Wu, J.; Jiang, Z.; Zhao, J.; Wang, R.; Lou, A.; Zhu, D.; Shi, G.P.; Yang, M. Microarray Expression
Profile of Circular RNAs in Peripheral Blood Mononuclear Cells from Rheumatoid Arthritis Patients.
Cell. Physiol. Biochem. 2017, 42, 651–659. [CrossRef] [PubMed]
102. Fang, Y.; Ma, M.; Wang, J.; Liu, X.; Wang, Y. Circular RNAs play an important role in late-stage gastric cancer:
Circular RNA expression profiles and bioinformatics analyses. Tumour Biol. 2017, 39. [CrossRef] [PubMed]
103. Guo, W.; Zhang, J.; Zhang, D.; Cao, S.; Li, G.; Zhang, S.; Wang, Z.; Wen, P.; Yang, H.; Shi, X.; et al.
Polymorphisms and expression pattern of circular RNA circ-ITCH contributes to the carcinogenesis of
hepatocellular carcinoma. Oncotarget 2017, 8, 48169–48177. [CrossRef] [PubMed]
104. Wu, N.; Jin, L.; Cai, J. Profiling and bioinformatics analyses reveal differential circular RNA expression in
hypertensive patients. Clin. Exp. Hypertens. 2017, 39, 454–459. [CrossRef] [PubMed]
105. Zhao, Z.; Li, X.; Gao, C.; Jian, D.; Hao, P.; Rao, L.; Li, M. Peripheral blood circular RNA hsa_circ_0124644 can
be used as a diagnostic biomarker of coronary artery disease. Sci. Rep. 2017, 7, 39918. [CrossRef] [PubMed]
106. Bazan, H.A.; Hatfield, S.A.; Brug, A.; Brooks, A.J.; Lightell, D.J., Jr.; Woods, T.C. Carotid Plaque Rupture Is
Accompanied by an Increase in the Ratio of Serum circR-284 to miR-221 Levels. Circ. Cardiovasc. Genet. 2017,
10. [CrossRef] [PubMed]
107. Iparraguirre, L.; Munoz-Culla, M.; Prada-Luengo, I.; Castillo-Trivino, T.; Olascoaga, J.; Otaegui, D. Circular
RNA profiling reveals that circular RNAs from ANXA2 can be used as new biomarkers for multiple sclerosis.
Hum. Mol. Genet. 2017, 26, 3564–3572. [CrossRef] [PubMed]
108. Liu, Y.; Cui, H.; Wang, W.; Li, L.; Wang, Z.; Yang, S.; Zhang, X. Construction of circular miRNA sponges
targeting miR-21 or miR-221 and demonstration of their excellent anticancer effects on malignant melanoma
cells. Int. J. Biochem. Cell Biol. 2013, 45, 2643–2650. [CrossRef] [PubMed]
109. Lee, T.; Awano, H.; Yagi, M.; Matsumoto, M.; Watanabe, N.; Goda, R.; Koizumi, M.; Takeshima, Y.;
Matsuo, M. 2′-O-Methyl RNA/Ethylene-Bridged Nucleic Acid Chimera Antisense Oligonucleotides to
Induce Dystrophin Exon 45 Skipping. Genes 2017, 8. [CrossRef] [PubMed]
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
